Skip to main content
Equibles

Aries Wealth Management

Position in EDIT — Editas Medicine, Inc.

CIK 1729515 PORTLAND, ME
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$40,500
+$9,625 QoQ
Shares Held
12,500
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#131
of 215 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aries Wealth Management holds $2,513,233 across 8 Biotechnology names. EDIT ranks #6 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 4,000 $979,080
2 KOD
Kodiak Sciences Inc.
 25,000 $974,000
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 605 $300,521
4 VSTM
Verastem, Inc.
 30,833 $117,782
5 ABEO
Abeona Therapeutics Inc.
 12,500 $77,250
6 EDIT
Editas Medicine, Inc.
This page 		12,500 $40,500
7 MTVA
MetaVia Inc.
 10,000 $14,300
8 TCRX
TScan Therapeutics, Inc.
 10,000 $9,800

All Filings in EDIT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,500 12,500
2026-03-31 $30,875 12,500
2025-12-31 $25,625 12,500
2025-09-30 $43,375 12,500
2025-06-30 $29,700 13,500
2025-03-31 $16,066 13,850
2024-12-31 $17,589 13,850
2024-09-30 $47,228 13,850
2024-06-30 $64,679 13,850
2021-06-30 $226,560 4,000
2020-12-31 $280,440 4,000